Micro Lab News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Dublin, Oct. 31, 2023 (GLOBE NEWSWIRE) -- The "Global Pharmaceutical Pellets Market Report 2023" report has been added to ResearchAndMarkets.com's offering. The global pharmaceutical pellets market is on the cusp of substantial expansion, with a projected increase from $1.48 billion in 2022 to $1.66 billion in 2023, representing a compound annual growth rate (CAGR) of 12.3%. Furthermore, the pharmaceutical pellets market is anticipated to reach $2.54 billion by 2027, with a CAGR of 11.2%. This s

The property, spread over 13,000 sq ft with a built-up area of 3,951 sq ft in the Jubilee Hills area, was bought from Manoj Kumar Tibrewala.

(This story has not been edited by THE WEEK and is auto-generated from a PTI

Get latest articles and stories on Business at LatestLY. New Delhi [India], August 16: Micro Labs Ltd, a renowned pharmaceutical company, proudly announced the launch of Trisopt, the world's first fixed-dose combination of Brimonidine, Timolol, and Brinzolamide ophthalmic suspension for glaucoma management. Trisopt is an indigenous development from Micro Labs, manufactured in their state-of-the-art facility located in Sikkim. Business News | Micro Labs Ltd Introduces Trisopt: World's First Triple Drug Fixed-dose Combination for Glaucoma Management.

Owner Tayla Bennett sprouts business from a hobby.